Get the Stockscreener App
4.33
2.61%
0.11
After Hours:
4.34
0.010
+0.23%
Sight Sciences Inc stock is traded at $4.33, with a volume of 146.62K.
It is up +2.61% in the last 24 hours and up +23.01% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
See More
Previous Close:
$4.22
Open:
$4.25
24h Volume:
146.62K
Relative Volume:
0.45
Market Cap:
$235.57M
Revenue:
$77.36M
Net Income/Loss:
$-38.43M
P/E Ratio:
-5.845
EPS:
-0.7408
Net Cash Flow:
$-29.92M
1W Performance:
-0.69%
1M Performance:
+23.01%
6M Performance:
-13.92%
1Y Performance:
+47.78%
1-Day Range:
$4.18
$4.361
1-Week Range:
$3.845
$4.46
52-Week Range:
$2.74
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.33 | 229.58M | 77.36M | -38.43M | -29.92M | -0.7408 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Sight Sciences Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Sight Sciences Publishes Its 2025 Sustainability Report - VisionMonday.com
Sight Sciences to Present at Two Upcoming Investor Conferences - The Manila Times
Sight Sciences maps out two May investor conference appearances - Stock Titan
Sight Sciences (SGHT) to Release Earnings on Wednesday - MarketBeat
Sight Sciences Issues 2025 Sustainability Report on ESG Initiatives - VisionMonday.com
Sight Sciences awarded $55.4 million in patent case against Alcon By Investing.com - Investing.com Canada
Sight Sciences awarded $55.4 million in patent case against Alcon - Investing.com
Sight Sciences Wins Patent Judgment, Secures Ongoing Royalties - TipRanks
Sight Sciences (NASDAQ: SGHT) awarded $55.4M and 10% Hydrus royalty - Stock Titan
Sight Sciences Announces the Release of its Sustainability Report - The Manila Times
Sight Sciences (NASDAQ: SGHT) details 2026 meeting, director elections and auditor vote - Stock Titan
Sight Sciences will detail first-quarter results after market close May 6 - Stock Titan
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 - marketscreener.com
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sight Sciences wins $34M patent ruling against Alcon - MSN
KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus
SGHT: Momentum builds for interventional glaucoma and dry eye, with innovation and adoption accelerating - TradingView
If You Invested $1,000 in Sight Sciences, Inc. (SGHT) - Stock Titan
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Sight Sciences CFO Rodberg sells $25,670 in shares By Investing.com - Investing.com India
Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com Canada
Sight Sciences CLO Hayden sells shares worth $48,851 - Investing.com
Sight Sciences CFO Rodberg sells $25,670 in shares - Investing.com
Sight Sciences (NASDAQ:SGHT) CFO James Rodberg Sells 7,231 Shares of Stock - MarketBeat
Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan
Sight Sciences (SGHT) legal chief sells 13,761 shares for RSU tax obligations - Stock Titan
KCK Ltd. reports 1.44M shares in Sight Sciences (SGHT) — 2.7% stake - Stock Titan
Bull Bear: Does ITRI offer margin of safetyWeekly Profit Analysis & Smart Investment Allocation Tips - baoquankhu1.vn
Will Sight Sciences (SGHT) Stock Fall Further | Price at $3.53, Up 0.86%Industry Analysis - Newser
Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Cuts Target Price to $4.35 - Moomoo
Affiliate notice: SGHT (NASDAQ: SGHT) proposes common-share sale tied to vesting - Stock Titan
SGHT (NASDAQ: SGHT) sale notice: 13,761 restricted shares vesting - Stock Titan
Is Sight Sciences (SGHT) Stock Good for Passive Investors | Price at $3.56, Up 1.28%Momentum Surge - UBND thành phố Hải Phòng
Published on: 2026-04-05 14:40:16 - baoquankhu1.vn
SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) - Investing.com Australia
Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells 8,168 Shares of Stock - MarketBeat
Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) By Investing.com - Investing.com South Africa
Sight Sciences (NASDAQ:SGHT) EVP Brenton Taylor Sells 2,869 Shares - MarketBeat
Sight Sciences (NASDAQ:SGHT) CEO Sells 29,244 Shares - MarketBeat
Sight Sciences CEO Badawi sells $108k in shares By Investing.com - Investing.com India
[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):